A phase 1/1b study to evaluate the safety and tolerability of immunotherapy combinations in participants with breast or gynaecologic malignancies [AB928CSP0002].

  • Richardson, Gary (Primary Chief Investigator (PCI))
  • Baker, Emma (Project Manager)

Project: Research

StatusActive
Effective start/end date28/02/1931/12/24

Keywords

  • Medical Oncology
  • Breast and gynaecologic malignancies
  • Clinical trial